Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy

The American Journal of Cardiology

Volumn 66, Issue 19, 1990, Pages 1348-1354

  Stevenson, Lynne Warner ^a   Tillisch, Jan H ^a   Hamilton, Michele ^a   Luu, Michael ^a   Chelimsky Fallick, Catherine ^a   Moriguchi, Jaime ^a   Kobashigawa, Jon ^a   Walden, Julie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIGOXIN; HYDRALAZINE; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

ADULT; BLOOD PRESSURE; CARDIOMYOPATHY, CONGESTIVE; CORONARY DISEASE; DEATH, SUDDEN; FEMALE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0025245005     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(90)91166-4     Document Type: Article

References (30)

1. Timing of transplantation in idiopathic dilated cardiomyopathy
2. Predictors of total mortality and sudden death in mild to moderate heart failure
3. Veterans Administration Cooperative Study on vasodilator therapy of heart failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate
4. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
5. Factors influencing the one-year mortality of dilated cardiomyopathy
6. The limited reliability of physical signs for the estimation of hemodynamics in chronic heart failure
7. Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe congestive heart failure
8. Maintenance of cardiac output with normal filling pressures in dilated heart failure
9. Efficacy of medical therapy for severe congestive heart failure in patients referred for urgent cardiac transplantation
10. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure
11. Cardiac transplantation: selection, immunosuppression and survival
12. Results of long-term vasodilator therapy in patients with refractory congestive heart failure
13. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril
14. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses
15. Effects of enalopril on mortality in severe congestive heart failure
16. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure
17. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance
18. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure
19. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
20. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
21. The predictability of mitral regurgitation detected by doppler echocardiography in patients referred for cardiac transplantation
22. Late death after myocardial infarction: mechanisms, etiologies, and implications for prevention of sudden death
23. Programmed ventricular stimulation in severe heart failure: high, short-term risk of sudden death despite noninducibility
24. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity
25. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
26. Registry of the International Society for Heart Transplantation Fifth Official Report-1988
27. Donor availability as the primary determinant of the future of heart transplantation
28. Sudden unexpected death in patients with congestive heart failure: a second frontier